| Condition | Pre- Treatment (N = 82) | Session 1 (N = 77) | Session 6 (N = 58) | Session 11 (N = 49) | Session 16 (N = 30) | Post- Treatment (N = 67) |
---|---|---|---|---|---|---|---|
QIDS-SR | ACT | 14.96 (4.15) | 15.06 (4.63) | 11.76 (5.08) | 11.21 (6.16) | 8.84 (5.84) | 8.10 (6.54) |
CBT | 14.61 (4.55) | 13.57 (4.71) | 11.24 (5.32) | 9.68 (5.66) | 8.23 (4.92) | 6.34 (5.28) | |
DAS-17 | ACT | 63.36 (17.80) | 62.15 (19.83) | 61.03 (17.89) | 59.51 (21.54) | 52.42 (16.40) | 50.03 (17.42) |
CBT | 60.55 (19.95) | 59.67 (22.91) | 54.33 (18.94) | 55.91 (17.23) | 51.01 (16.12) | 46.56 (16.91) | |
EQ-D | ACT | 34.96 (5.41) | 33.91 (6.65) | 33.06 (6.28) | 35.58 (7.40) | 37.63 (7.52) | 37.58 (7.57) |
CBT | 34.45 (5.61) | 33.89 (6.95) | 32.08 (6.97) | 33.78 (5.29) | 36.04 (7.29) | 37.13 (5.28) | |
AAQ-II | ACT | 23.77 (6.95) | 23.36 (7.70) | 24.96 (7.80) | 27.92 (9.71) | 30.20 (10.60) | 30.77 (9.57) |
CBT | 23.71 (7.61) | 26.52 (8.92) | 27.71 (8.89) | 25.71 (8.92) | 30.17 (8.86) | 30.97 (8.70) |